Publications

Detailed Information

Long-term response to mood stabilizer treatment and its clinical correlates in patients with bipolar disorders: a retrospective observational study

DC Field Value Language
dc.contributor.authorAhn, Sung Woo-
dc.contributor.authorBaek, Ji Hyun-
dc.contributor.authorYang, So-Yung-
dc.contributor.authorKim, Yongkang-
dc.contributor.authorCho, Youngah-
dc.contributor.authorChoi, Yujin-
dc.contributor.authorLee, Kounseok-
dc.contributor.authorPark, Taesung-
dc.contributor.authorHong, Kyung Sue-
dc.date.accessioned2017-07-11T06:28:00Z-
dc.date.available2017-07-24T10:54:19Z-
dc.date.issued2017-07-09-
dc.identifier.citationInternational Journal of Bipolar Disorders, 5(1):24-
dc.identifier.uri10.1186/s40345-017-0093-5-
dc.identifier.urihttps://hdl.handle.net/10371/117782-
dc.description.abstractBackground
The efficacy and utility of long-term prophylactic treatment in patients with bipolar disorders (BDs) have not been fully explored. This study aims to estimate the long-term clinical response of patients with BDs to mood stabilizer treatment and to identify the clinical factors associated with that response.

Methods
The study subjects consisted of 80 patients with bipolar I or bipolar II disorder who had been receiving treatment with lithium and/or valproate for more than 2 years at a single bipolar disorder clinic. The long-term response to the best treatment option based on treatment algorithms was evaluated using the Alda scale. Clinical characteristics were evaluated on a lifetime basis. Patients were classified into two response groups based on frequentist mixture analysis using the total Alda scale score.

Results
Thirty-four percent of the patients were good responders, with a total Alda score of 5 or higher. The treatment response rate did not differ between the lithium and valproate groups, but lithium and valproate combination therapy was associated with poorer response. The number of previous mixed episodes was associated with a worse response (p=0.026). Of individual symptoms, delusions during manic episodes (p=0.008) and increased appetite (p=0.035) during depressive episodes were more common in moderate/poor responders than in good responders. Co-morbid anxiety disorders were more frequently observed in the moderate/poor response group (p=0.008).

Conclusions
Psychotic, mixed, and atypical features of BDs were found to be correlated with long-term treatment outcomes. Lithium and valproate showed similar efficacy but moderate/poor responders preferred to use polypharmacy.
-
dc.titleLong-term response to mood stabilizer treatment and its clinical correlates in patients with bipolar disorders: a retrospective observational study-
dc.typeArticle-
dc.contributor.AlternativeAuthor안성우-
dc.contributor.AlternativeAuthor백지현-
dc.contributor.AlternativeAuthor양소영-
dc.contributor.AlternativeAuthor김용강-
dc.contributor.AlternativeAuthor조영아-
dc.contributor.AlternativeAuthor최유진-
dc.contributor.AlternativeAuthor이건석-
dc.contributor.AlternativeAuthor박태성-
dc.contributor.AlternativeAuthor홍경수-
dc.language.rfc3066en-
dc.rights.holderThe Author(s)-
dc.date.updated2017-07-09T03:24:02Z-
Appears in Collections:
Files in This Item:

Altmetrics

Item View & Download Count

  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Share